Health care

Former HDL execs win access to $4M of insurance policy

HDL True Health no signage ftd

Several of HDL’s former higher-ups, including two of its co-founders, will be able to tap into some of the company’s insurance policy to cover legal fees, although several argued that the money won’t be enough.

VCU, HDL alums launch firm to fight liver disease

Sanyal Marioneaux, Caffrey, Carroll

With a celebrated VCU medical professor at the helm, a pharmaceutical startup is hoping to raise $3 million to begin work with drug developers battling two widespread types of liver disease.

True Health’s tests draw patent lawsuit

HDL True Health no signage ftd

The company that bought HDL out of bankruptcy is now facing its own legal troubles: An Ohio competitor, which had a testing deal with HDL, is claiming patent infringement and demanding True Health to stop performing some tests.

HDL founder attempts to tap $10M insurance policy

Facing lawsuits from the federal government and a major insurer, Tonya Mallory is pushing for access to HDL’s $10 million policy for current and former executives.

Local family takes over medical billing firm

MMSI Tammy Schilke ftd

A longtime local firm that helps medical practices manage their billing is now under the ownership of a local family, which plans to grow the Monument Avenue business and its staff.

HDL founder calls for dismissal of federal suit

Former HDL chief executive Tonya Mallory has fired back at the federal government and called for the dismissal of its suit against her, which alleges that she played a key part in a kickback scheme.

Q&A: Picking up the pieces of HDL

In the midst of integrating the beleaguered HDL with his own blood testing firm, True Health Diagnostics CEO Chris Grottenthaler sat down with BizSense to talk about the challenges of bringing the two companies together and how he was able to see past HDL’s baggage.

HDL creditors to investigate execs, board members

A bankruptcy judge gave a group of HDL’s creditors the go-ahead to conduct an investigation into the reported massive amounts of cash paid out to some of the company’s former executives and most of its current board members.